We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $140.5 · 12 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
SPONSORED SEGMENT: Encompass Health Rehabilitation Hospital of Sarasota - ABC7 WWSB
SPONSORED SEGMENT: Encompass Health Rehabilitation Hospital of Sarasota ABC7 WWSB
Encompass Health Plans New 36-Bed Rehabilitation Hospital in Bridgeport - citybiz
Encompass Health Plans New 36-Bed Rehabilitation Hospital in Bridgeport citybiz
Encompass Health to build 36-bed hospital in West Virginia By Investing.com - Investing.com Australia
Encompass Health to build 36-bed hospital in West Virginia By Investing.com Investing.com Australia
Encompass Health plans 36-bed rehabilitation hospital in Bridgeport - StreetInsider
Encompass Health plans 36-bed rehabilitation hospital in Bridgeport StreetInsider
Encompass Health to build 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia - PR Newswire
Encompass Health to build 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia PR Newswire
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 04. 30. | After market close (AMC) | $1.48 | — | — | $1.57B | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $1.48 | — | — | $1.46B | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $3.28 | — | — | $3.97B | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $2.22 | — | — | $2.62B | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 28. | TD Cowen | — | Initiate coverage | — → Buy | — | TD Cowen: Buy |
| 2026. 05. 05. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 02. 07. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 10. 31. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 10. 02. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2025. 09. 16. | Keybanc | — | Maintain | Overweight → Overweight | — | Keybanc: Overweight |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 2,222,101 | $214.94B | 0.18% | — | New position |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 804,946 | $85.44B | 0.13% | — | New position |
| 3 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 695,567 | $73.83B | 0.12% | — | New position |